MedPath

The observation of the clinical effect after Acupoint catgut embedding treatment treating swallowing dysfunction after radiotherapy for nasopharyngeal carcinoma

Phase 1
Conditions
nasopharyngeal carcinoma
Registration Number
ITMCTR2000004128
Lead Sponsor
Hanzhong Central Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Malignant neoplasms at the top and lateral walls of the nasopharyngeal cavity were confirmed;
2. Regular hospitalization and complaints of dysphagia;
3. Head and neck surgery experts determined that there was a swallowing disorder;
4. Aged 30 to 80 years;
5. It can complete the filling of Anderson rating scale independently or with the help of researchers, and can cooperate with the drinking water test in low-lying fields;
6. Expected lifetime & GT 6 months;
7. Informed and agreed, voluntary acceptance, good compliance of patients.

Exclusion Criteria

1. Pregnancy or lactation;
2. Patients with cardiovascular and cerebrovascular diseases, endocrine system, hematopoietic system, digestive system, serious primary diseases and mental diseases;
3. Patients with mental and perceptual impairments;
4. Patients with clotting disease, thrombocytopenia or other hemorrhagic diseases;
5. Sepsis or bacteremia patients;
6. There were lymphedema patients in acupoint embedding area;
7. Patients who are afraid of acupoint embedding or;
8. If the therapy has been treated surgically, the swallowing function will be irreversible, which will cause disturbance to the results of this study.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Standardized Swallowing Assessment, SSA;Water Swallow Test, WST;Functional Oral Intake Scale, FOIS;M.D. Anderson Dysphagia Inventory, MDADI;
Secondary Outcome Measures
NameTimeMethod
Digital imaging assessment;
© Copyright 2025. All Rights Reserved by MedPath